IP Verse

Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer - EP3498734B1

PatentPatent Analysis

EP3498734

MERCK SHARP & DOHME
Application Number
EP18205542A
Filing Date
Feb 3, 2015
Status
Granted And Under Opposition
Jul 30, 2021
Grant Date
Sep 1, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3165220B2
EP3283882B2
EP3678654B1

Bibliography

The patent EP3498734B1 was granted to Merck Sharp & Dohme on Sep 1, 2021 following the initial filing on Feb 3, 2015 under the application number EP18205542A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KONIG SZYNKA TILMANN VON RENESSEJun 1, 2022ADMISSIBLE
PAJAROMay 31, 2022ADMISSIBLE
POHLMANMay 31, 2022ADMISSIBLE
BOULT WADE TENNANTMay 27, 2022ADMISSIBLE
SYMBIOSISMay 26, 2022ADMISSIBLE
HOFFMANN EITLEMay 20, 2022ADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 13, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents